Autosomal dominant polycystic kidney disease-clinical challenges

Middle East Journal of Anesthesiology

Volumn 17, Issue 2, 2003, Pages 205-218

  Fields, Aron ^c   Richards, Todd ^a   Frost, Elizabeth ^b   Kaye, Alan D ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b Mt Siani Dept of Anesthesiology   (United States)

^c NONE

Author keywords

Anesthesia; Kidney; Polycystic; Renal failure

Indexed keywords

3 DEACETYLVECURONIUM; ATRACURIUM; CISATRACURIUM; DESFLURANE; ENFLURANE; FENTANYL; ISOFLURANE; MORPHINE; MUSCLE RELAXANT AGENT; REMIFENTANIL; SEVOFLURANE; SUFENTANIL; SUXAMETHONIUM; UNCLASSIFIED DRUG; VECURONIUM;

ANESTHESIA; ANESTHESIST; AUTOSOMAL DOMINANT DISORDER; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG CLEARANCE; DRUG METABOLISM; GASTROINTESTINAL TRACT; GENETIC RISK; HEART DISEASE; HUMAN; IMAGING SYSTEM; INTENSIVE CARE; INTUBATION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY METABOLISM; KIDNEY POLYCYSTIC DISEASE; MORBIDITY; NERVE BLOCK; PATIENT CARE; PHYSICAL EXAMINATION; PREOPERATIVE CARE; TECHNIQUE; TREATMENT PLANNING; CHRONIC KIDNEY FAILURE; REVIEW;

HUMANS; KIDNEY FAILURE, CHRONIC; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 0642274956     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. AGODOA LYC, HELD PJ, PORT FK: United States RDS. United States Renal Data System 1998 Annual Data Report. Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1998.
2. GRANTHAM JJ: The pathogenesis, etiology, and treatment of autosomal dominant kidney disease: recent advances. Am J Kidney Dis 28:788-803.
3. GABOW PA: Autosomal Dominant Polycystic Kidney Disease? More than a renal disease. Am J Kidney Dis 16:403-413, 1990.
4. RAVINE D, WALKER RG, GIBSON RN, SHEFFIELD LJ, KINCAIDE-SMITH P, DANKS DM: Treatable complication in undiagnosed cases of autosomal dominant polycystic kidney disease. Lancet 337:127-129, 1991.
5. BREUNING MH, REEDERS ST, BRUNNER H, IJDO JW, SARIS JJ, VERWEST A, VAN OMMEN GJ, PEARSON PL: Improved early diagnosis of adult polycystic kidney disease with flanking DNA markers. Lancet 2:1359-1361, 1987.
6. PERAL B, ONG AC, SAN MILAN JL, GAMBLE V, REES L, HARRIS PC: A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD 1). Hum Mol Genet 5:539-542, 1995.
7. MILUTINOVIC J, RUST PF, FIALKOV PJ, ADODOA LY, PHILLIPS LA, RUDD TG, SUTHERLAND S: Intra-familial phenotypic expression of autosomal dominant kidney disease. Am J Kidney Dis 19:465-472, 1992.
8. BEGLEITER ML, SMITH TH, HARRIS DJ: Ultrasound for genetic counseling in polycystic kidney disease. Lancet 2:1073-1074, 1977.
9. GABOW PA, KIMBERLING WJ, STRAIN JD, MANGO-JOHNSON ML, JOHNSON AM: Utility of ultrasonography in the diagnosis of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 8:105-110, 1997.
10. ELLES RG, HODKINSON KA, MALLICK NP, O'DONOGHUE DJ, READ AP, RIMMER S, WATTERS EA, ET AL: Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register. J Med Genet 31:115-120, 1994.
11. GREGIRE JR, TORRES V, HOLY KE, FARROW GM: Renal epithelial hyperplastic and neoplastic proliferation and autosomal dominant polycystic kidney disease. Am J Kidney Dis 9:27-38, 1987.
12. GRANTHAM JJ, ET AL: Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease. Proc Assoc Am Physicians 109:397-408, 1997.
13. GABOW PA, KAEHNY WD, JOHNSON AM, DULEY IJ, MANGO-JOHNSON M, LEZOTTE DC, SCHRIER RW: The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 35:675-680, 1990.
14. GRAHAM PC, LINDHOP GBM: The anatomy of the rennin-secreting cell in adult polycystic kidney disease. Kidney Int 33:1084-1090, 1988.
15. TORRES VE, DONOVAN KA, SCICLI G, HOLLEY KE, THIBODEAU SN, CARRETERO OA, INANGAMI T, ET AL: Synthesis of rennin by tubulocystic epithelium in autosomal dominant polycystic kidney disease. Kidney Int 42:364-373, 1992.
16. FICK GM, DULEY IT, JOHNSON AM, STRAIN JD, MANCO-JOHSNON ML, GABOW PA: The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 4:1654-1660, 1994.
17. BENNETT WM, ELZINGA L, GOLPER TA, BARRY JM: Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. J Urol 137:620-622, 1987.
18. WATSON NL, MACNICOL AM, ALLAN PL, WRIGHT AF: Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int 41:206-210, 1992.
19. CHAPMAN AB, JOHNSON AM, RAINGUET S, HOSSACK K, GABOW P, SHRIER RW: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8:1292-1297, 1997.
20. SHARPE C, JOHNSON A, GABOW P: Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 10:1908-1914, 1999.
21. CONTRERAS G, MERCADO A, PARDO V, VAAMONDE CA: Nephrotic syndrome in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6:1354-1359, 1995.
22. TORRES VE, WILSON DM, HATTERY RR, SUGURA JW: Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22:513-519, 1993.
23. DELAKAS D, DASKALOPOULOS G, CRANIDAS A: Extra corporeal shock wave lithotripsy for urinary calculi in autosomal dominant polycystic kidney disease. J Endourol 11:167-170, 1997.
24. SKLAR AH, CARUANA RJ, LAMMIERS JE, STRAUSER GD: Renal infections in ADPKD. Am J Kidney Dis 10:81-88, 1987.
25. CHAPMAN AB, THICKMAN D, GABOW PA: Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney diseases. Am J Kidney Dis 16:252-255, 1990.
26. GABOW PA, JOHNSON AM, KAEHNY WD, KINBERLING WJ, LEZOTTE DC, DULEY IT, JOHNS RH: Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease. Kidney Int 41:1311-1319, 1992.
27. ZEIR M, GEBERTH S, GONZALO A, CHAVEAU D, GRUNFELD JP, RITZ E: The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:1119-1123, 1992.
28. Walser M, Mitch WE, Maroni BJ, Kopple JB: Should protein be restricted in predialysis patients? Kidney Int 55:771-777, 1999.
29. ECDER T, EDLESTIEN CL, BRSNAHAN GM, JOHNSON AM, GABOW PA, SHRIER RW: Effect on renal function of diuretics versus angiotensin converting enzyme (ACE) inhibitors in hypertensive patients with autosomal dominant polycystic kidney disease (ADPKD). J Am Soc Nephrol 10:415-424, 1999.
30. WATSON ML, MACNICOL AM, BORG-COSTANZI J: A long-term comparison of the effects on renal function of blood pressure control with either atenolol or analopril in polycystic kidney disease. J Am Soc Nephrol 10:428-434, 1999.
31. DAOUST MC, REYNOLDS DM, BICHET DG, ET AL: Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25:733-736, 1995.
32. PHAKDEEKITCHAROEN P, WATNICK TJ, AHN C, ET AL: 13 novel mutations of the replicated legion of PKD 1 in an Asian population. Kidney Int 58:1400-1412, 2000.
33. WATNIK T, GERMINO GG: Molecular basis of autosomal dominant polycystic kidney disease. Sem Nephrol 19:327-343, 1999.
34. KOPTIDES M, DELTAS CC: Autosomal dominant polycystic kidney disease: molecular genetics and molecular pathogenesis. Hum Gent 107:115-126, 2000.
35. LEDERMAN ED, MCCOY G, Conti DJ, Lee EC: Diverticulitis and polycystic kidney disease. Am Surg 66:200-203, 2000.
36. TORRA R, NICLAU C, BADENAS C, NAVARRO S, PEREZ L, EXTIVILL X, DARNELL A: Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease. Clin Nephrol 47:19-22, 1997.
37. GABOW PA, JOHNSON AM, KAEHNEY WD, MANGO-JOHNSON ML, DULEY IT, EVERSON GT: Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11:1033-1037, 1990.
38. SHAUVEAU D, PIRSON Y, LE MOINE A, FRANCO D, BELGHITI J, GRUNFELD JP: Extrarenal manifestations in autosomal polycystic kidney disease. Adv Nephrol Necker Hosp 26:265-289, 1997.
39. KATKHOUDA N, HURWITZ M, GUGENHEIM J, MAVOR E, MASON RJ, WALDREP DJ, RIVERA RT, ET AL: Laparascopic management of benign solid and cystic lesions of the liver. Ann Surg 229:460-464, 1999.
40. NORBY SM, TERRES VE: Complications of autosomal polycystic kidney disease in hemodialysis patients. Semin Dial 13:30-35, 2000.
41. TIMIO M, MONARCA C, PEDE S, GENTILI S, VERDURA C, LOLLI S: The spectrum of cardiovascular abnormalities in autosomal polycystic kidney disease: a 10-year follow-up in a five-generational kindred. Clin Nephrol 37:245-251, 1992.
42. VAN DIJK MA, HOGEWIND BL, BREUNING MH, RINKEL GJ: Intracranial aneurysms and autosomal polycystic kidney disease. Ned Tigdschr Geneeskd 144:1280-1283, 2000.
43. SEAR J: Effect of renal function and failure. In Park GR, Sladen RN (eds): Sedation and Anesthesia in the Critically Ill. Oxford, Blackwell Science, pp. 108-29, 1995.
44. MOUQUET C, BITKER MO, BAILLIART O, ET AL: Anesthesia for creation of a forearm fistula in patients with endstage renal failure. Anesthesiology 70:909-914, 1989.
45. DHONNEUR G, REBAINE C, SLAVOV V, ET AL: Neostigmine reversal of Vecuronium neuromuscular block and the influence of renal failure. Anesth Analg 82:134-138, 1996.
46. MILLER RD, WAY WL, HAMILTON WK, ET AL: Succinylcholine-induced hyperkalemia in patients with renal failure? Anesthesiology 36:138-141, 1972.
47. CONZEN PF, NUSCHELER M, MELOTTE A, ET AL: Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg 81:569-575, 1995.
48. D'HONNEUR G, GILTON A, SANDOUK P, ET AL: Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine: The influence of renal failure. Anesthesiology 81:87-93, 1994.
49. KOEHNTOP DE, RODMAN JH: Fentanyl pharmacokinetics in patients undergoing renal transplant action. Pharmacotherapy 17:746-752, 1997.